ServicenavigationHauptnavigationTrailKarteikarten

Research unit
INNOSUISSE
Project number
124.137 IP-LS
Project title
Addressing Immune Checkpoint Resistance in Glioma with Dual-Siglec Inhibition

Participants

Research organisation: Innosuisse
Swiss Innovation Agency
Einsteinstrasse 2
CH-3003 Bern
+41 58 461 61 61 (Call Center)
info@innosuisse.ch
www.innosuisse.ch/
Contact person

 Simone Schmitt
Memo Therapeutics AG
www.uid.admin.ch/Detail.aspx?uid_id=CHE428742263

Scientific management
Universitätsspital Basel
www.uid.admin.ch/Detail.aspx?uid_id=CHE115173213

Scientific management
Universität Basel

Implementation Partner


Memo Therapeutics AG
www.uid.admin.ch/Detail.aspx?uid_id=CHE428742263